IndiaDoctors at Narayana Health in West Bengal successfully treated a seven-year-old boy with thalassaemia using a haplo-cord transplant, which involved stem cells from his father and cord blood from his sibling. The child required monthly blood transfusions but is now transfusion-free after recovery. In another case, a 62-year-old man from Myanmar with primary CNS lymphoma was treated with CAR T-cell therapy, a type of immunotherapy, after conventional treatments failed. Both patients faced significant health challenges during treatment, but both recovered. Dr. Joydeep Chakrabartty highlighted these cases as landmark achievements in medical science, while Prasanta Chowdhury discussed the complexities of cord blood banking, including the debate between private storage and public donation.
Bias read (Center): The article presents medical advancements without overt ideological framing. While it mentions the broader implications of cord blood banking and CAR T-cell therapy, it does not take a clear stance on policy, ethics, or political issues related to healthcare access or funding. The focus remains on医疗
